CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 375 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02003196
NCT02003196N/ACompleted

Effects of Viral Reactivation on Outcomes of Brain-injured Patients ( IBIS-VIRUS)

Nantes University Hospital·observational·Posted Dec 6, 2013·Updated Aug 25, 2021

In Brief

An observational study for Brain Injury. Completed, enrolled 375 participants across 1 site.

Detailed Summary

Morbidity and mortality of ICU patients is increased by the development of a "immunosuppression" systemic (IS). This IS develops in the early hours of hospitalization and is responsible for severe infections, including viral reactivations (Cytomegalovirus or Herpes Simplex Virus). Viral reactivation was associated with increased morbidity and mortality in intensive care units. In clinical practice, they are searched at the onset of organ failure or unexplained fever. The investigators wish to conduct this research in the stroke patients to assess the predictive power of these viral reactivations on the duration of mechanical ventilation.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBrain Injury
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 6, 2013
Enrollment StartJan 5, 2014
Primary CompletionMar 26, 2020
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 12.6 years ago